TMS therapy for Miami — outpatient TRD care, 65 minutes from home.

For adults in Brickell, Coral Gables, or Aventura, RECO Integrated Psychiatry's Delray Beach office sits roughly 65 minutes up I-95. The TMS program runs the FDA-cleared 10 Hz protocol over the left DLPFC at 120% of the patient's own resting motor threshold across 36 sessions, with iTBS available when a three-minute daily chair time is the difference between a feasible course and no treatment. Board-certified psychiatrists handle diagnostic clarification, motor threshold mapping, prior authorization, and weekly PHQ-9 tracking directly — not delegated to a technician.

For adults commuting up from Brickell, Coral Gables, or Coconut Grove, the run north on I-95 to RECO Integrated Psychiatry’s Delray Beach office runs about 50 miles and roughly 65 minutes without traffic — long enough that most Miami patients consolidate their transcranial magnetic stimulation course into a predictable morning-block schedule rather than treating each session as a same-day round trip. That geographic buffer is part of the clinical calculation: distance from the ambient stressors driving a treatment-resistant depressive episode is often useful during weeks three through six, when response begins to emerge. The paragraphs below describe how the outpatient TMS therapy program is structured for patients driving from Aventura, Pinecrest, or downtown Miami.

Insurance-covered TRD candidacy and how we document it

Commercial coverage for repetitive TMS in major depressive disorder is uniformly gated by treatment-resistant depression (TRD) criteria. Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS all require two documented adequate antidepressant trials — typically defined as six or more weeks at a therapeutic dose with confirmed adherence, drawn from at least two distinct pharmacologic classes. An adequate SSRI trial of sertraline or escitalopram followed by an SNRI trial of venlafaxine or duloxetine is a common pattern; augmentation with aripiprazole, lithium, or quetiapine at documented target doses is often also required. A concurrent or prior course of evidence-based psychotherapy — CBT, ACT, or interpersonal therapy — is usually part of the payer criteria.

For patients whose treatment history is fragmented across primary-care prescribers, telehealth platforms, and community psychiatrists in Dade and Broward, reconstruction is done at intake. The psychiatry team pulls pharmacy fill records, prior-authorization letters, and outside notes, then compiles the payer-specific TRD documentation packet. Historical PHQ-9 scores are used where available, and a baseline PHQ-9 and GAD-7 are administered at the consult to anchor the current episode.

Peer-to-peer reviews with the payer’s medical director are handled by the psychiatry team, not by billing staff. Prior authorization is typically completed within seven to fourteen business days.

Motor threshold mapping and the first week

Session one is dedicated to motor threshold determination. The clinician positions the figure-of-eight coil over the left primary motor cortex and delivers single pulses of increasing intensity until the minimum stimulator output that reliably evokes a visible right-thumb (abductor pollicis brevis) twitch in five of ten trials is identified. Treatment intensity for the depression protocol is then set at 120% of that resting motor threshold. The dorsolateral prefrontal cortex target is localized either by the standard 5-cm rule or, when available, by Beam F3 coordinates for improved anatomical accuracy.

Sessions two through five acclimate the patient to the stimulation. Scalp discomfort — a percussive tapping sensation over the coil site — is most prominent in the first week; adjustments to coil angle and topical anesthetic can help, and tolerance improves substantially by session six. Transient tension-type headache after the first several sessions is common and responds to acetaminophen. The standard 10 Hz protocol delivers approximately 3,000 pulses per session in four-second trains separated by 26-second intertrain intervals.

Patients drive themselves to and from treatment, return to work the same day, and do not require sedation or post-session monitoring. There is no cognitive impairment, no anesthesia recovery, and no restriction on operating a vehicle before or after the appointment.

Standard 10 Hz versus intermittent theta burst (iTBS)

The FDA-cleared standard protocol at 10 Hz over the left DLPFC runs approximately 20 to 40 minutes per session depending on the device. Intermittent theta burst stimulation (iTBS), cleared in 2018 based on the THREE-D non-inferiority trial, delivers an equivalent 600-pulse treatment dose in approximately three minutes per session. For a Miami-based patient driving roughly 130 miles round-trip, the difference between 40 minutes and three minutes of chair time is not cosmetic — it often determines whether the six-week course is logistically feasible around work.

Response and remission rates for iTBS and standard 10 Hz are statistically comparable in the pivotal literature. Payer reimbursement, however, is not always symmetric: some commercial plans reimburse iTBS at parity, while others still classify it as investigational or reimburse at a reduced rate. The psychiatry team verifies iTBS-specific coverage in the benefits check before the treatment plan is finalized.

For obsessive-compulsive disorder, treatment is delivered on a deep TMS (H7 coil) platform with a distinct protocol: 20 Hz stimulation over the medial prefrontal cortex and anterior cingulate following individualized symptom provocation, with the YBOCS as the primary outcome measure. Deep TMS for OCD requires a separate prior authorization and is not interchangeable with the depression protocol.

Response, taper, and the retreatment question

Published response rates for rTMS in treatment-resistant major depression run 40-60%, with remission rates in the 25-40% range across the major registries. Response typically emerges between sessions 15 and 25 — meaning weeks three through five of the acute course. Patients and referring clinicians should not interpret an absent early response as failure; the psychiatry team tracks weekly PHQ-9 and GAD-7 trajectories and reviews trend rather than any single score.

The full FDA-cleared course is 36 sessions across six to nine weeks: 30 daily sessions Monday through Friday, followed by a six-session taper delivered three, then two, then one time per week. The taper reduces early relapse risk and is generally required for insurance-covered courses to be considered complete.

Responders who relapse later — typically six to twelve months after the acute course — are candidates for a second full course, and commercial payers generally cover retreatment on documentation of prior response (usually a 50% PHQ-9 reduction) and current relapse. Maintenance TMS on a weekly or biweekly schedule is a separate coverage question and is evaluated case by case.

What the first visit actually looks like

The intake is a 60-minute psychiatric evaluation with a board-certified psychiatrist, not a screening call. The visit covers diagnostic clarification — unipolar versus bipolar depression matters, because bipolar depression is a relative contraindication to standard TMS without concurrent mood stabilization — a full medication and psychotherapy history, seizure-risk screening, and a review of implanted metallic or electronic devices near the head.

PHQ-9, GAD-7, and, where indicated, the ASRS for adult ADHD or the YBOCS for obsessive-compulsive symptoms are administered. If the clinical picture suggests a role for adjunctive intervention — esketamine (Spravato), an antidepressant regimen change, augmentation with buspirone or aripiprazole, or referral for structured CBT, DBT, or EMDR — that is discussed in the same visit rather than deferred to a separate consult.

Insurance and admissions logistics from Miami

RECO Integrated Psychiatry is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS for outpatient psychiatric services, including TMS when TRD criteria are documented. Benefits verification is completed before the consult so the patient understands deductible status, coinsurance, and per-session copay before scheduling begins.

For Miami patients, the admissions team typically batches the intake, motor threshold session, and first several treatments into consecutive mornings to reduce round trips during the acclimation week. After week one, the schedule stabilizes into a single daily appointment — 30-40 minutes for standard 10 Hz, roughly three minutes for iTBS — that most patients slot around a normal work day.

Serving residents of: Brickell, Coral Gables, Coconut Grove, Aventura, Pinecrest.